vimarsana.com

Page 8 - மூலதனம் மருத்துவ பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study finds up to 24 percent of esophagectomy patients can develop VTE post-operatively

 E-Mail Boston, MA (May 1, 2021) - A new study presented today at the AATS 101st Annual Meeting, found that the percentage of patients undergoing esophagectomy for cancer who suffer Venous Thromboembolism (VTE) post-operatively is much higher than previously reported, with as many as 24 percent suffering from Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE). Six-month mortality for patients with VTE was 17.6 percent compared to 2.1 percent for those without. Venous Thromboembolism (VTE) is a common, potentially preventable post-operative complication leading to significant morbidity and mortality. Esophagectomy patients are amongst the highest risk groups for VTE due to disease burden, magnitude of surgery and high rate of perioperative morbidity. The study aimed to quantify the true incidence of VTE post esophagectomy, associated risk factors, and the impact of VTE on patients outcomes.

How Brain Tumors Turn Immune Cells into Cancer-Growing Hostages

How Brain Tumors Turn Immune Cells into Cancer-Growing Hostages
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

17 April 2021 Coronavirus Charts and News: More Exercise Linked to Lower Chance of Severe COVID-19 COVID Is Sending Little Kids To Hospitals

The U.S. new cases 7-day rolling average are 6.7 % HIGHER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 24.8 % LOWER than the rolling average one week ago. Today s posts include: U.S. Coronavirus New Cases are 74,312 U.S. Coronavirus deaths are at 909 U.S. Coronavirus immunizations have been administered to 59.3 % of the population The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths improved J&J Tries to Distance Itself From AstraZeneca Vax What we know about the super-rare blood clots linked to the J&J vaccine

Researchers identify risk factors for SARS-CoV-2 reinfection

A team of scientists from the Capital Medical University and Peking University, China, has recently explored the factors responsible for the reactivation of SARS-CoV-2 infection among individuals who have recently recovered from COVID-19. The findings reveal that individuals with lower lymphocyte count or with two or fewer symptoms during the first COVID-19 episode are at higher risk of recurrent infection.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.